Cargando…
Supplementation with NAD(+) and Its Precursors to Prevent Cognitive Decline across Disease Contexts
The preservation of cognitive ability by increasing nicotinamide adenine dinucleotide (NAD(+)) levels through supplementation with NAD(+) precursors has been identified as a promising treatment strategy for a number of conditions; principally, age-related cognitive decline (including Alzheimer’s dis...
Autor principal: | Campbell, Jared M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370773/ https://www.ncbi.nlm.nih.gov/pubmed/35956406 http://dx.doi.org/10.3390/nu14153231 |
Ejemplares similares
-
Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements
por: Tadokoro, Koh, et al.
Publicado: (2020) -
NAD(+) Precursors: A Questionable Redundancy
por: Canto, Carles
Publicado: (2022) -
Supplemental Nicotinic Acid Elevates NAD(+) Precursors in the Follicular Fluid of Mares
por: Pollard, Charley-Lea, et al.
Publicado: (2022) -
Supplementing media with NAD(+) precursors enhances the in vitro maturation of porcine oocytes
por: POLLARD, Charley-Lea, et al.
Publicado: (2021) -
NAD(+) Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis
por: Obrador, Elena, et al.
Publicado: (2021)